Purpose

The purpose of this study is to find out if a psychotherapy method called brief behavioral activation (BBA) can improve depression, anxiety, and overall well-being and encourage healthy lifestyle behaviors in English- and Spanish-speaking Older Adult Cancer Survivors (OACS). BBA is a therapeutic technique that guides people to set goals and engage in enjoyable or rewarding activities as a way of changing behavior and reducing symptoms of depression. In this study, BBA will be given by telephone or videoconference (remotely).

Condition

Eligibility

Eligible Ages
Over 65 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • As per self-report or medical record, ≥65 years old - As per self-report or medical record, has a history of cancer - As per medical record and/or self-report: - currently with no evidence of disease (NED) AND/OR - 6 months or more post-treatment - Fluent in English or Spanish, as per self-reported fluency of "well" or "very well"* - As per self-report, able to communicate over video-conference and/or phone for sessions - Elevated score on the PHQ-9: ≥8 (N/A for Training Case participants) - Received a Blessed Orientation-Memory-Concentration Scale (BOMC) score of ≤ 11 (N/A for Training Case participants)

Exclusion Criteria

  • As per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9, they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale (CSSR) (MSK Standard) to determine level of risk;. Only those with active suicidal ideation will be excluded and referred to a higher level of care. - As per self-report or as documented in the medical record, current untreated (e.g., no medication, no therapy) major psychotic disorder (schizotypal personality disorder, schizophreniform disorder, schizoaffective disorder). Patients diagnosed with a major psychiatric disorder will be reviewed by the study PI to determine eligibility prior to consent. - As per self-report or medical record, currently taking antidepressant medication for < 3 month - As per self-report, engagement in regular individual psychotherapeutic support that the participant is unable or unwilling to put on hold for the course of the study - [MSK patients only] As per medical record, patient has impaired decision-making capacity - Language verification: Prior to enrollment, patients will be asked the following two questions by research staff to verify English or Spanish fluency necessary for participation in the study: 1. How well do you speak English/ Spanish? (must respond "Well" or "Very well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused) 2. What is your preferred language for healthcare? (must respond English or Spanish)

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential Assignment
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Behavioral Activation for Older Adult Cancer Survivor ( BBA-OAC)
Involves 10 30-50-minute telephone and/or video-conference sessions with structured agendas for interventionists consisting of: 1. Psychoeducation about depression and the rationale for BBA-OACs, and invitation to share one's cancer story and ongoing medical and psychosocial concerns 2. Compilation of a list of pleasant and rewarding social, physical, and recreational activities in line with participants' values 3. Daily activity scheduling; and 4. Self-monitoring of satisfaction and mood
  • Other: assessments (questionnaires)
    Complete assessments (questionnaires) before the intervention begins (at baseline), after the last session (around Week 10) and a follow-up assessment at Week 18 (or approximately 2 months after the sessions end.
Active Comparator
Supportive Psychotherapy (SP)
Full SP participants (not training case participants) will also complete 10 sessions, 30-50 minutes each, over the telephone or video-conference with SP-trained interventionists.
  • Other: assessments (questionnaires)
    Complete assessments (questionnaires) before the intervention begins (at baseline), after the last session (around Week 10) and a follow-up assessment at Week 18 (or approximately 2 months after the sessions end.

Recruiting Locations

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey 07920
Contact:
Rebecca Saracino, PhD
646-888-0263

Memorial Sloan Kettering at Monmouth (Limited Protocol Activities)
Middletown, New Jersey 07748
Contact:
Rebecca Saracino, PhD
646-888-0263

Memorial Sloan Kettering at Bergen (Limited Protocol Activities)
Montvale, New Jersey 07645
Contact:
Rebecca Saracino, PhD
646-888-0263

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)
Commack, New York 11725
Contact:
Rebecca Saracino, PhD
646-888-0263

Memorial Sloan Kettering at Westchester (Limited Protocol Activities)
Harrison, New York 10604
Contact:
Rebecca Saracino, PhD
646-888-0263

Memorial Sloan Kettering Cancer Center
New York, New York 10065
Contact:
Rebecca Saracino, PhD
646-888-0263
jamesr@mskcc.org

Memorial Sloan Kettering at Nassau (Limited Protocol Activities)
Uniondale, New York 11553
Contact:
Rebecca Saracino, PhD
646-888-0263

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Rebecca Saracino, PhD
646-888-0263
jamesr@mskcc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.